Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 030144/0060 | |
| Pages: | 9 |
| | Recorded: | 04/03/2013 | | |
| Attorney Dkt #: | BAYM.P0018US/11304160 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/15/2016
|
Application #:
|
13820931
|
Filing Dt:
|
04/03/2013
|
|
Publication #:
|
|
Pub Dt:
|
01/02/2014
| | | | |
|
Title:
|
IMMUNOTHERAPY OF CANCER USING GENETICALLY ENGINEERED GD2-SPECIFIC T CELLS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/15/2016
|
Application #:
|
13820931
|
Filing Dt:
|
04/03/2013
|
|
Publication #:
|
|
Pub Dt:
|
01/02/2014
| | |
PCT #:
|
US2011050780
|
|
Title:
|
IMMUNOTHERAPY OF CANCER USING GENETICALLY ENGINEERED GD2-SPECIFIC T CELLS
|
|
|
Assignee
|
|
|
|
|
| ONE BAYLOR PLAZA |
| BCMD 600 D, MAILSTOP BCM210 |
| HOUSTON, TEXAS 77030 |
|
|
Correspondence name and address
|
| |
ANNIE AYMOND / FULBRIGHT & JAWORSKI
|
| |
1301 MCKINNEY STREET
|
| |
HOUSTON, TX 77010
|
Search Results as of:
06/17/2024 03:23 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
